EVALUATION OF SENTINEL LYMPH NODE IMAGING AND BIOPSY USING TECHNETIUM-99M RADIOISOTOPE IN EARLY-STAGE BREAST CANCER PATIENTS AT K HOSPITAL

Dao Thanh Binh1, Le Hong Quang1, Vu Hong Thang2
1 Department of Breast Surgery, K Hospital
2 Department of Oncology, Hanoi Medical University

Nội dung chính của bài viết

Tóm tắt

Objectives: To evaluate the outcomes of sentinel lymph node imaging and biopsy using the Technetium-99m (Tc-99m) radioisotope in patients with early-stage breast cancer and to analyze factors associated with axillary lymph node metastasis.


Subjects and Methods: A retrospective descriptive study was conducted on 55 patients with early-stage breast cancer treated at the Department of Breast Surgery, K Hospital, from June 2021 to September 2021. Patients underwent sentinel lymph node imaging using Tc-99m and sentinel lymph node biopsy during surgery, followed by comparison with the histopathological results of axillary lymph node dissection specimens. Evaluated indicators included the sentinel lymph node detection rate, number of sentinel lymph nodes identified, rate of sentinel lymph node metastasis, and analysis of factors associated with lymph node metastasis.


Results: The sentinel lymph node detection rate was 96.4%. The mean number of sentinel lymph nodes identified was 1.8 ± 0.6 nodes per patient. The sentinel lymph node metastasis rate was 23.6%. The sensitivity of sentinel lymph node biopsy was 92.3%, while specificity reached 100%. No severe complications related to the technique were recorded. Factors associated with axillary lymph node metastasis included histopathological type (p < 0.05), histological grade (p < 0.05), and lymphovascular invasion (LVI) status (p < 0.05).


Conclusion: Sentinel lymph node biopsy using Tc-99m is a safe, feasible, and highly accurate method for evaluating axillary lymph node status in patients with early-stage breast cancer. This technique contributes to reducing unnecessary axillary lymph node dissection and minimizing postoperative complications.

Chi tiết bài viết

Tài liệu tham khảo

1. Canavese, G., et al., Sentinel Lymph Node Biopsy Versus Axillary Dissection in Node-Negative Early-Stage Breast Cancer: 15-Year Follow-Up Update of a Randomized Clinical Trial. Annals of Surgical Oncology, 2016. 23: p. 2494–2500.
2. Zahoor, S., et al., Sentinel Lymph Node Biopsy in Breast Cancer: A Clinical Review and Update. Journal of Breast Cancer, 2017. 20: p. 217–227.
3. Bhattacharya, A., et al., Abstract B042: Sentinel lymph node detection in breast cancer: Comparison of blue dye and filtered Technetium 99m sulphur colloid radiotracer injection. Cancer Research, 2023.
4. Chen, H., et al., Correlation Analysis of Pathological Features and Axillary Lymph Node Metastasis in Patients with Invasive Breast Cancer. Journal of Immunology Research, 2022. 2022.
5. Wang, L., et al., Development of a Machine Learning Model Integrating Pathomics and Clinical Data to Predict Axillary Lymph Node Metastasis in Breast Cancer: A Two‐Center Study. Cancer Reports, 2025. 8.
6. Babu, A., S. S, and J. Jose, AXILLARY LYMPH NODE METASTASIS IN SONOLOGICALLY NODE-NEGATIVE BREAST CARCINOMA. Asian Journal of Pharmaceutical and Clinical Research, 2024.
7. Mok, C., et al., Network meta‐analysis of novel and conventional sentinel lymph node biopsy techniques in breast cancer. BJS Open, 2019. 3: p. 445–452.